FDA Import Refusal SCS-9805476-2/11/2 — SIGNATURE PHARMACEUTICAL
The FDA refused shipment SCS-9805476-2/11/2 from SIGNATURE PHARMACEUTICAL (India) on Feb 25, 2022. The refused product falls under Drugs and Biologics — IVERMECTIN (ANTI-PROTOZOAL, A-LEISHMANIAL, ANTI-MALARIAL). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Feb 25, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62LCA47 IVERMECTIN (ANTI-PROTOZOAL, A-LEISHMANIAL, ANTI-MALARIAL)
- Charges
- 75